UK markets closed

NLS Pharmaceutics Ltd. (NLSP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.1327+0.0002 (+0.15%)
At close: 04:00PM EDT
0.1429 +0.01 (+7.69%)
After hours: 07:47PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
7,816
8,977
5,919
99.58
Selling general and administrative
6,528
6,506
5,941
2,200
Total operating expenses
14,344
15,482
11,861
2,299
Operating income or loss
-14,344
-15,482
-11,861
-2,299
Interest expense
91.815
100.866
68.134
233.7
Total other income/expenses net
-1,032
-912.45
-17.323
-328.365
Income before tax
-15,468
-16,496
-11,946
-2,861
Income from continuing operations
-15,468
-16,496
-11,946
-2,861
Net income
-15,468
-16,496
-11,946
-2,861
Net income available to common shareholders
-15,468
-16,496
-11,946
-2,861
Basic EPS
-0.50
-0.84
-1.00
-0.27
Diluted EPS
-0.50
-0.84
-1.00
-0.27
Basic average shares
30,824
19,683
11,902
11,779
Diluted average shares
30,824
19,683
11,902
11,779